Using an interactive DVD about type 2 diabetes and insulin therapy in a UK South Asian community and in patient education and healthcare provider training

2015 ◽  
Vol 98 (9) ◽  
pp. 1123-1130 ◽  
Author(s):  
Naina Patel ◽  
Margaret A. Stone ◽  
Michelle Hadjiconstantinou ◽  
Steve Hiles ◽  
Jacqui Troughton ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Patient Education ◽  
Insulin Therapy ◽  
Healthcare Provider ◽  
South Asian ◽  
Provider Training ◽  
Asian Community ◽  
South Asian Community

scholarly journals Do Cultural and Psychosocial Factors Contribute to Type 2 Diabetes Risk? A Look Into Vancouver's South Asian Community

2020 ◽  
Vol 44 (1) ◽  
pp. 14-21
Author(s):  
Tricia S. Tang ◽  
Khalif Halani ◽  
Parmjit Sohal ◽  
Paul Bains ◽  
Nadia Khan
Keyword(s):  
Type 2 Diabetes ◽  
Psychosocial Factors ◽  
South Asian ◽  
Diabetes Risk ◽  
Asian Community ◽  
South Asian Community

scholarly journals Type 2 diabetes and cardiovascular risk in the UK south Asian community

Diabetologia ◽  
2006 ◽  
Vol 50 (1) ◽  
pp. 244-244
Author(s):  
A. H. Barnett ◽  
A. N. Dixon ◽  
S. Bellary ◽  
M. W. Hanif ◽  
J. P. O’Hare ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
South Asian ◽  
Asian Community ◽  
South Asian Community ◽  
The Uk

scholarly journals Type 2 diabetes and cardiovascular risk in the UK south Asian community

Diabetologia ◽  
2006 ◽  
Vol 49 (10) ◽  
pp. 2234-2246 ◽  
Author(s):  
A. H. Barnett ◽  
A. N. Dixon ◽  
S. Bellary ◽  
M. W. Hanif ◽  
J. P. O’Hare ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
South Asian ◽  
Asian Community ◽  
South Asian Community ◽  
The Uk

Should insulin therapy be started earlier in type 2 diabetes?

2008 ◽  
Vol 41 (10) ◽  
pp. 8
Author(s):  
MARTIN J. ABRAHAMSON ◽  
BARRY J. GOLDSTEIN
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy

Clinical Experience with Insulin Detemir: Results from the Bangladesh Cohort of Global A1chieve Study

2013 ◽  
Vol 3 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Zafar Ahmed Latif ◽  
Md. Faruque Pathan ◽  
Md. Nazrul Islam Siddiqui ◽  
MA Mannan ◽  
SM Ashrafuzzaman ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Weight ◽  
Glycaemic Control ◽  
Insulin Therapy ◽  
Hba1c Level ◽  
Insulin Detemir ◽  
Entire Cohort ◽  
Baseline Visit ◽  
Effective Option

Objective: To present results from the Bangladesh cohort of the A1chieve study receiving insulin detemir (Levemir) ± oral anti diabetic drugs. Methods: Out of 1093 patients recruited from 49 sites in Bangladesh, 370 were initiated on insulin detemir (Levemir).Study visits were defined as baseline, interim (around 12 weeks from baseline) and final (around 24 weeks from baseline) visit. Results: Glycaemic control was poor in all the groups at baseline. In the entire cohort at 24 weeks, significant reductions from baseline were observed in mean HbA1c (from 10.0 % to 7.2%, p<0.001), FPG (from 10.5 to 6.7 mmol/L, p<0.001) and PPPG (from 15.3 to 8.9 mmol/L, p<0.001) levels. Overall 45.5% of the participants achieved target HbA1c level of < 7% after 24 weeks. The rate of all hypoglycaemic events in the entire cohort reduced from 1.34 (baseline) to 0.12 events/person year after 24 weeks of insulin detemir therapy (p<0.0001). There was no clinically relevant change in body weight in insulin naïve or prior insulin users groups after 24 weeks of insulin detemir therapy. Conclusions: The current study suggests that insulin detemir may be considered as a safe and effective option for initiating insulin therapy for type 2 diabetes in Bangladesh. Birdem Med J 2013; 3(1): 11-18 DOI: http://dx.doi.org/10.3329/birdem.v3i1.17121

Sign in / Sign up

Export Citation Format

Share Document